Update from investor relations
CBDC, Novatti BillPay & Banking
Good morning,
I am pleased to report on some operational milestones achieved at Novatti Group (ASX: NOV) over the past month, which include:
- Chosen to participate in the RBA’s digital currency test project
- Launched Novatti BillPay enabling digital bill payments in 6 new currencies, further extending our reach
RBA digital currency project
Novatti has been chosen to participate in a Reserve Bank of Australia research project to explore the potential use cases and economic benefits of a Central Bank Digital Currency (CBDC) in Australia.
By participating in this project, Novatti will help shape the future of CBDCs and promote the use cases for high governance stablecoins in Australia. Novatti's own stablecoin, AUDD, was created with a focus on compliance, security and utility, all of which will support the innovative CBDC project.
Our participation again highlights how Novatti is considered a leading player in digital payments in Australia and capable of scaling established technology into new use cases.
You can read more about our role in this project by clicking here.
Novatti BillPay
I am also pleased to confirm the launch of our Novatti BillPay platform which is an expansion of our established ChinaPayments business. Using Novatti BillPay, customers in Hong Kong, Indonesia, the Philippines, Malaysia, Thailand and South Korea can pay Australian bills such as tuition, accommodation and utilities with their local currency via popular digital wallets. We are seeing strong growth in this area as international students return to Australia.
SVB crisis – how is Australia different
As flagged to the market, Novatti does not have any banking accounts with SVB and we do not anticipate any material change to our operations from its receivership. Last week, Novatti was featured in the Financial Review discussing how Australia’s banking landscape is different to that of the US, which you can read in full here.
Australia’s banking industry operates very differently to the US, with very high regulation making it rightly difficult to become a bank. The flip side of this is that once a banking licence is secured, this creates high barriers to entry for other players, which further strengthens the business case of the International Bank of Australia (IBOA), in which Novatti holds a 91% stake, which was granted a restricted banking licence in November 2022. I was invited to discuss the circumstances around SVB and the difference in the Australian regulatory environment on ABC Radio National with a transcript available here.
As part of our strategy and positioning for IBOA, we have always said there is an exciting opportunity to leverage technology to meet the needs of modern businesses and consumers. We will continue to build on this strategy this year in pursuit of a full banking licence.
Thank you for your ongoing interest in Novatti and I look forward to bringing you further news next month.
Kind regards,
Peter Cook
Managing Director
Novatti Group Limited
Investors can view all Novatti announcements and discuss our latest news at the Novatti Investor Community.
Shareholders can also update their mailing preferences online via our share registry Automic.-->
December Quarter Investor Briefing
Recorded 31 January 2023
-->
International Bank of Australia Presentation
Released 7 November 2022
-->
Novatti Digital Payment Services Explainer
Copyright © 2023 Novatti Group Limited, All rights reserved.
You are receiving this email because you are a shareholder, an advisor or you have subscribed to ommunications with Novatti Group.
Our mailing address is:Novatti Group Limited
Level 3, 461 Bourke StreetVIC3000
Australia
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
- Forums
- ASX - By Stock
- Novatti - The $1 party
Update from investor relations CBDC, Novatti BillPay &...
- There are more pages in this discussion • 313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOV (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.46M |
Open | High | Low | Value | Volume |
5.0¢ | 5.2¢ | 5.0¢ | $3.185K | 63.56K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13200 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 75440 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13200 | 0.050 |
4 | 80408 | 0.049 |
3 | 294206 | 0.048 |
2 | 153138 | 0.047 |
1 | 16055 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 75440 | 1 |
0.055 | 81000 | 2 |
0.056 | 51783 | 1 |
0.057 | 10000 | 1 |
0.060 | 115000 | 1 |
Last trade - 15.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
5.2¢ |
  |
Change
0.000 ( 1.89 %) |
|||
Open | High | Low | Volume | ||
5.0¢ | 5.3¢ | 5.0¢ | 121940 | ||
Last updated 15.10pm 06/05/2024 ? |
Featured News
NOV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online